Suraksha Diagnostic Ltd. (IN:SURAKSHA)
:SURAKSHA
Want to see IN:SURAKSHA full AI Analyst Report?
SURAKSHA Stock Chart & Stats
₹300.85
-₹13.40(-3.48%)
At close: 4:00 PM EST
₹300.85
-₹13.40(-3.48%)
Day’s Range― - ―
52-Week Range₹224.10 - ₹353.65
Previous CloseN/A
Volume140.52K
Average Volume (3M)1.23K
Market Cap
₹13.86B
Enterprise Value₹15.92B
Total Cash (Recent Filing)₹435.94M
Total Debt (Recent Filing)₹1.18B
Price to Earnings (P/E)43.2
Beta1.13
Next Earnings
Aug 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)6.13
Shares Outstanding52,080,757
10 Day Avg. Volume1,073
30 Day Avg. Volume1,225
Financial Highlights & Ratios
PEG Ratio32.20
Price to Book (P/B)4.85
Price to Sales (P/S)3.82
P/FCF Ratio70.61
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)7.7
Revenue Forecast (FY)₹3.35B
Bulls Say, Bears Say
Bulls Say
Consistent Multi-year Revenue GrowthMulti-year top-line expansion and a clear rebound from FY23 indicate durable demand for diagnostics services. Sustained revenue growth supports scale benefits, capacity utilisation and long-term investment in network expansion and service capabilities, strengthening competitive positioning.
Healthy Operating And EBITDA MarginsRobust operating and EBITDA margins reflect operational leverage in the diagnostics business and underlying pricing or cost advantages. These margins provide persistent earnings base and the ability to fund working capital, reinvest in equipment, and support service quality over multiple years.
Operating Cash Flow Stronger Than Reported EarningsConsistently positive operating cash generation above accounting profits signals high earnings quality and internal liquidity. Durable OCF offers flexibility to fund growth, manage seasonal working capital, and service obligations without relying solely on external financing.
Bears Say
Margin Volatility And Recent CompressionMaterial margin swings suggest exposure to pricing pressure, cost inflation or adverse mix that can persist. If structural, compressed margins reduce cash available for reinvestment and lower long-term profitability, making returns more sensitive to competitive and input-cost shifts.
Rising Leverage Since FY25An increasing debt load elevates financing costs and reduces balance-sheet flexibility. Persistently higher leverage constrains the firm's ability to invest opportunistically, withstand demand shocks, or accelerate capex, raising refinancing and solvency risks over the medium term.
Weak And Volatile Free Cash Flow ConversionLow FCF-to-income ratio indicates substantial cash tied up in capex or working capital, limiting capacity to reduce debt, pay dividends, or self-fund expansion. Volatile FCF makes long-term planning harder and increases reliance on external funding in adverse periods.
Suraksha Diagnostic Ltd. News
SURAKSHA FAQ
What was Suraksha Diagnostic Ltd.’s price range in the past 12 months?
Suraksha Diagnostic Ltd. lowest stock price was ₹224.10 and its highest was ₹353.65 in the past 12 months.
What is Suraksha Diagnostic Ltd.’s market cap?
Suraksha Diagnostic Ltd.’s market cap is ₹13.86B.
When is Suraksha Diagnostic Ltd.’s upcoming earnings report date?
Suraksha Diagnostic Ltd.’s upcoming earnings report date is Aug 07, 2026 which is in 54 days.
How were Suraksha Diagnostic Ltd.’s earnings last quarter?
Suraksha Diagnostic Ltd. released its earnings results on May 21, 2026. The company reported ₹1.21 earnings per share for the quarter, beating the consensus estimate of N/A by ₹1.21.
Is Suraksha Diagnostic Ltd. overvalued?
According to Wall Street analysts Suraksha Diagnostic Ltd.’s price is currently Overvalued.
Does Suraksha Diagnostic Ltd. pay dividends?
Suraksha Diagnostic Ltd. does not currently pay dividends.
What is Suraksha Diagnostic Ltd.’s EPS estimate?
Suraksha Diagnostic Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Suraksha Diagnostic Ltd. have?
Suraksha Diagnostic Ltd. has 52,080,757 shares outstanding.
What happened to Suraksha Diagnostic Ltd.’s price movement after its last earnings report?
Suraksha Diagnostic Ltd. reported an EPS of ₹1.21 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 4.73%.
Which hedge fund is a major shareholder of Suraksha Diagnostic Ltd.?
Currently, no hedge funds are holding shares in IN:SURAKSHA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Suraksha Diagnostic Ltd.
Founded in Kolkata in 1992 as Suraksha Diagnostics & Eye Centre (P) Ltd., the company revolutionized diagnostic services in the city by being among the first to offer a full spectrum of pathology and radiology services under one roof. This integrated approach, coupled with an unwavering commitment to precision and patient care, led to consistent growth and widespread recognition. Within just three years, they expanded their footprint by opening a second center in Siliguri, North Bengal. This Siliguri facility continues to be the largest diagnostic center in the region, serving patients not only from North Bengal but also from neighboring states and countries. Since then, Suraksha Diagnostic Limited has continued its steady expansion, establishing a presence across Bengal, Bihar, and the Delhi National Capital Region.
Technical Analysis
Krsnaa Diagnostics Limited
―
Dr. Lal PathLabs Limited
―
Metropolis Healthcare Ltd.
―
Thyrocare Technologies Ltd
―
Vimta Labs Limited
―